Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6020 Target Snapshot

Bile salt export pump · SINGLE PROTEIN · Homo sapiens

1,475Compounds
80Assays
194Approved Drugs
1,710.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O95342. Use UniProt O95342 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O95342 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Bile salt export pump as ChEMBL target CHEMBL6020, mapped to UniProt O95342. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Bile salt export pump
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL6020
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O95342
Bile salt export pump
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Bile salt export pump is the right protein anchor across sources, using UniProt O95342 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBile salt export pump
UniProt AccessionO95342
Component TypeProtein
Sequence Length1321 aa

Bile salt export pump

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Bile salt export pump, mapped to UniProt O95342. Sequence length is 1321 aa.

Mapped IDO95342
Review nameBile salt export pump
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

194
Approved
14
Phase III
26
Phase II
Assay Mix

Activity Type Distribution

IC501,704.0
KI6.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1651956 6.96 IC50 110.0 Clinical
CHEMBL3704745 6.75 IC50 180.0 Preclinical
CHEMBL595 6.58 IC50 260.0 Approved
CHEMBL4162778 6.52 IC50 300.0 Preclinical
CHEMBL160 6.4 IC50 400.0 Approved
CHEMBL4159416 5.85 IC50 1400.0 Preclinical
CHEMBL5182534 5.85 IC50 1400.0 Preclinical
CHEMBL2103735 5.83 IC50 1470.0 Approved
CHEMBL472 5.82 IC50 1500.0 Approved
CHEMBL223643 5.81 IC50 1560.0 Preclinical
Distribution

pChEMBL Value Distribution

87
5.0
22
5.5
9
6.0
6
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PIOGLITAZONE
CHEMBL595
Approved 1999
CYCLOSPORINE
CHEMBL160
Approved 1983
Assay Landscape

Assay Landscape

80
Total Assays
476
Tested Compounds
4
Assay Types
Binding — 33 assays, 55 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 20 8 5.2
cell-based format 10 3 4.8
cell membrane format 2 41 5.0
assay format 1 3 6.0
ADME — 31 assays, 476 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 17 169 4.8
assay format 7 301 4.7
single protein format 5 6 4.8
tissue-based format 2 0
Functional — 13 assays, 22 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 7 6 4.8
cell-based format 5 16 4.6
assay format 1 0
Toxicity — 3 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 3 4.5
cell membrane format 1 2 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine